Index
Checking point of information
at the time of initial public offering.
AI Analysis
■AI Analysis
AI statistically analyzes IPO information to identify trends.
The closer the number is to 5, the higher the rate of increase in the initial price relative to the offering price.
| popularity | scale-criteria | offering-criteria | exchange-criteria | market-condition | Business-criteria |
| 1 | 2 | 4 | 5 | 4 | 1 |
*This is an analysis of trends and does not guarantee any results.
This is not a solicitation to buy or sell stocks, nor is it investment advice.
*Please check the disclaimer for details.
■AI Analysis Chart
A group of stocks listed in the past
with similar IPO condition trends
| Name | Rate of change
(Inicial Price) |
|
| -11.3% |
|
| +54.8% |
|
| +15.5% |
|
| +10.0% |
|
| -0.2% |
|
| +0.0% |
CompanyOverview
- Company Name：Cyfuse Biomedical KK
- Business：バイオ3Dプリンタを用いた、再生医療等製品の開発・製造・販売.
- The industry sector is Pharmaceutical.
- Scheduled to be listed on TSE-Growth.
- The company size is that assumed market capitalization is
approx. 95 Million JPY (excluded public offering), approx. 116 Million JPY (included public offering).
- The lead manager is ＳＢＩ.
https://www.cyfusebio.com/
Initial Public Offering Memo
■ Market Cap | Offering rate | Dilution rate | lock-up information
- The company size is assumed market capitalization is
approx. 95 Million JPY (excluded new issues), approx. 116 Million JPY (included new issues).
- The total amount of new issues is 20.3 Million JPY.
- The total amount of public offering is 8.2 Million JPY.
- The dilution ratio from the new issues is 21%.
- Rate of offering is aprrox. 9%.
- The number of outstanding shares is 5,894,500 shares (excluded new issues),
7,144,500 shares (included new issues).
- The number of diluted shares for stock acquisition rights is 862,000 shares.
- Date of 90-day lockup release (initially scheduled) is February 28, 2023.
- Date of 180-day lockup release (initially scheduled) is May 29, 2023.
■ Book building schedule | Payment schedule
- Book building Period *1：November 15, 2022(Tue.) - November 21, 2022(Mon.)
- Priced date *2 ：November 22, 2022(Tue.)
- Payment Period *3 ：November 24, 2022(Thu.) - November 29, 2022(Tue.)
- Listing Date ：December 1, 2022(Thu.)
*1:(Period for applying lottery to obtain the right to purchase)
*2:(The date when the purchase price is determined)
*3:(Period for expressing your intent to purchase and payment,if you are selected in the lottery)
■ Detail of new issue or public offering
- Unit of application：100 shares (Minimum deposit amount is 162,000 JPY.)
- Assumed issue price：1745 JPY
- Tentatively price range：1470 JPY - 1620 JPY
- Public offering price：1620 JPY
- The initial price on listed：1720 JPY(＋6.2％)
- Newly Issued Shares：1,250,000 shares (Domestic：933,500 shares ＋ Overseas：316,500 shares)
- Public offering shares：508,600 shares (Domestic：508,600 shares ＋ Overseas：0 shares)
- Number of domestic unit：14,421 Unit
- The lead manager is ＳＢＩ証券.
- The another securities companies are 岡三証券/ＳＭＢＣ日興証券/三菱ＵＦＪモルガン・スタンレー証券/楽天証券/東洋証券/松井証券/水戸証券.
| ＳＢＩ |
岡三 |
ＳＭＢＣ日興 |
三菱ＵＦＪモルガン・スタンレー |
楽天 |
東洋 |
松井 |
水戸 |
| Lead |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
■ New issue or public offering - condition history
|
Update
date |
Assumed issue
price
(JPY) |
Tentatively
price range
(JPY) |
Public offering
price
(JPY) |
| Initial | 2022-10-27 | 1745 JPY | | |
| Application period | 2022-11-14 | | 1470 - 1620 JPY | |
| Priced | 2022-11-22 | | | 1620 JPY |
|
Update
date |
New issues
total shares |
New issues
(Overseas) |
PO&OA
total shares |
PO
(Domestic) |
PO
(Overseas) |
OA
(Domestic) |
OA
(Overseas) |
| Initial | 2022-10-27 | 1,250,000 | 0 | 508,600 | 279,300 | 0 | 229,300 | 0 |
| Application period | 2022-11-14 | 1,250,000 | 0 | 508,600 | 279,300 | 0 | 229,300 | 0 |
| Priced | 2022-11-22 | 1,250,000 | 316,500 | 508,600 | 279,300 | 0 | 229,300 | 0 |
※：( ) indicates the breakdown.
e.g. In the case of a PO(overseas), there are domestic and overseas allotments of the public offering, of which the overseas allotment is indicated.
PO : Public offering OA : Over allotment
